|
⚲
|
| Keyboard |
| Franson Timothy R
✚
|
|
|---|---|
| CIK # | 0001471650 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001471650] | |
| 4 | [0001471650] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Transcept Pharmaceuticals Inc | |
| Franson Timothy R | |
| K2 Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2023-09-21 | Disposed to issuer | 52,000 | ||
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2023-09-21 | Disposed to issuer | 20,000 | ||
|
Transcept Pharmaceuticals Inc PRTK
Stock option (right to buy) · derivative
|
2023-09-21 | Disposed to issuer | 20,000 | ||
|
Transcept Pharmaceuticals Inc PRTK
Stock option (right to buy) · derivative
|
2023-09-21 | Disposed to issuer | 12,000 | ||
|
Transcept Pharmaceuticals Inc PRTK
Stock option (right to buy) · derivative
|
2023-09-21 | Disposed to issuer | 6,000 | ||
|
Transcept Pharmaceuticals Inc PRTK
Stock option (right to buy) · derivative
|
2023-09-21 | Disposed to issuer | 5,000 | ||
|
Transcept Pharmaceuticals Inc PRTK
Stock option (right to buy) · derivative
|
2023-09-21 | Disposed to issuer | 7,000 | ||
|
Transcept Pharmaceuticals Inc PRTK
Stock option (right to buy) · derivative
|
2023-09-21 | Disposed to issuer | 7,000 | ||
|
Transcept Pharmaceuticals Inc PRTK
Stock option (right to buy) · derivative
|
2023-09-21 | Disposed to issuer | 5,000 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2023-06-22 | Grant | 42,500 | $0.00 | |
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2023-02-21 | Sell | 7,000 | $1.88 | 13,160 |
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2023-02-08 | Grant | 20,000 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2022-06-22 | Grant | 28,000 | $0.00 | |
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2022-02-16 | Grant | 20,000 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Common Stock
|
2021-09-13 | Buy | 7,000 | $2.12 | 14,840 |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2021-06-23 | Grant | 17,500 | $0.00 | |
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2021-02-18 | Grant | 9,000 | $0.00 | |
|
Transcept Pharmaceuticals Inc PRTK
Stock Option (right to buy) · derivative
|
2021-02-18 | Grant | 7,000 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2020-06-25 | Grant | 17,500 | $0.00 | |
|
Transcept Pharmaceuticals Inc PRTK
Common Stock
|
2020-02-19 | Grant | 9,000 | $0.00 | |
| showing 20 of 35 most recent transactions | |||||